Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades

Allogeneic hematopoietic cell transplantation (allo-HCT) is a promising treatment for adult acute lymphoblastic leukemia (ALL), an intractable hematological malignancy. The trends in allo-HCT outcomes over the past 30 years were examined to verify the efficacy of evolving treatment methods and to id...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishiwaki, Satoshi, Akahoshi, Yu, Morita-Fujita, Mari, Shimizu, Hiroaki, Uchida, Naoyuki, Ozawa, Yukiyasu, Fukuda, Takahiro, Tanaka, Masatsugu, Ikegame, Kazuhiro, Ota, Shuichi, Katayama, Yuta, Takahashi, Satoshi, Kawakita, Toshiro, Ara, Takahide, Onizuka, Makoto, Kimura, Takafumi, Tanaka, Junji, Atsuta, Yoshiko, Arai, Yasuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636313/
https://www.ncbi.nlm.nih.gov/pubmed/35737870
http://dx.doi.org/10.1182/bloodadvances.2022008032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636313/
https://www.ncbi.nlm.nih.gov/pubmed/35737870
http://dx.doi.org/10.1182/bloodadvances.2022008032

Ejemplares similares